Abbonarsi

Can chronic his bundle pacing be safely started in centers with lack of experience of this technique? Mid-term data from a multicentric registry - 06/01/20

Doi : 10.1016/j.acvdsp.2019.09.237 
C. Chaumont 1, , N. Auquier 2, E. Popescu 2, A. Milhem 3, A. Savoure 1, B. Godin 1, A. Mirolo 1, H. Eltchaninoff 1, F. Anselme 1
1 Cardiology, University Hospital of Rouen, Rouen 
2 Cardiology, Le Havre Hospital, Le Havre 
3 Cardiology, La Rochelle Hospital, La Rochelle, France 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Riassunto

Introduction

Right ventricular pacing (RVP) induces ventricular asynchrony in patients with normal QRS and increases the risk of heart failure and atrial fibrillation on long-term. His bundle pacing (HBP) is a physiological alternative to RVP. Interest in HBP has been hampered in part by technical challenges and limited implantation tool set. Recent studies showed that it was feasible and safe in expert centers with a vast experience of HBP. These results may not apply to less experienced centers.

Purpose

To evaluate feasibility and safety of permanent His bundle pacing in hospitals with limited technical training to this technique and to evaluate stability of His bundle capture (HBC) thresholds.

Methods

We included all patients who underwent pacemaker implantation with attempt of HBP in 3 hospitals between September 2017 and January 2019. All the 5 operators were novice for HBP. HBC thresholds were recorded at 3 months and 9 months follow-up.

Results

HPB was successful in 62 of 69 patients (89.9%); selective HBC was obtained in 48 patients while nonselective HBC occurred in 14 patients. Indication for pacemaker implantation was atrioventricular conduction disease in 39 patients, sinus node dysfunction in 6 patients and AV nodal ablation for non-controlled atrial arrhythmias in 24 patients. The mean procedure duration was 75±8min, and mean fluoroscopy duration was 10±2min The mean HBC threshold was 1.39±0.26V and did not increase at 3 months follow-up (1.08±0.25V, n=48 patients) and 9 months follow-up (1.37±0.31V, n=14 patients). Only 7 patients had HBC threshold>2.5V/0.5ms. There was no pericardial effusion, no pneumothorax and no device infection. Ventricular lead revision was required at 3 months in one patient for sudden threshold increase, without obvious dislodgement (Fig. 1).

Conclusion

His bundle pacing performed by novice operators to this technique appeared feasible and safe. The mean HBC threshold did not increase at 3 months and 9 months follow-up.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2019  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 12 - N° 1

P. 108-109 - gennaio 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Epicardial atrial fat and left atrium remodeling
  • A. Felder, M. Kibler, S. El Ghannudi-Abdo, P. Ohlmann, O. Morel, L. Jesel
| Articolo seguente Articolo seguente
  • Left ventricular wall thickness measured with computed tomography predicts clinical outcomes in patients receiving cardiac resynchronization therapy
  • V. Galand, B. Ghoshhajra, J. Szymonifka, S. Das, V. Barré, R.P. Martins, C. Leclercq, J. Hung, Q. Truong, J. Singh

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.